U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Winter Gardens Quality Foods, Inc. - 608240 - 10/01/2021
  1. Warning Letters


Winter Gardens Quality Foods, Inc. MARCS-CMS 608240 —

Delivery Method:
VIA Electronic Mail
Food & Beverages

Recipient Name
Thomas M. Bross
Recipient Title
Chief Executive Officer
Winter Gardens Quality Foods, Inc.

304 Commerce St.
New Oxford, PA 17350-1723
United States

Issuing Office:
Center for Food Safety and Applied Nutrition (CFSAN)

United States

Dear Thomas M. Bross,

The Food & Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter with CMS #608240, dated August 5, 2020. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations, or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Daniel W. Johnson
Compliance Officer
HAF Division East 2, Philadelphia Office
Office p hone: 215.717.3746
e-mail: Daniel.Johnson@fda.hhs.gov

Cc (via email):
Randy F. Pack, Program Division Director, District Director (randy.pack@fda.hhs.gov)
Robin M. Rivers, Director, Compliance Branch (Robin.Rivers@fda.hhs.gov)
Martin J. Guardia, Director, Investigations Branch (martin.guardia@fda.hhs.gov)
Margaret E. DiGennaro, Supervisory Consumer Safety Officer (Margaret.DiGennaro@fda.hhs.gov)

Back to Top